These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2138588)

  • 1. Reduced expression of the functionally active complement receptor for iC3b but not for C3d on an avirulent mutant of Candida albicans.
    Ollert MW; Wadsworth E; Calderone RA
    Infect Immun; 1990 Apr; 58(4):909-13. PubMed ID: 2138588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of avirulent clones of Candida albicans with reduced ability to recognize the CR2 ligand C3d.
    Franzke S; Calderone RA; Schaller K
    Infect Immun; 1993 Jun; 61(6):2662-9. PubMed ID: 8500905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of C3d receptors on Candida albicans.
    Calderone RA; Linehan L; Wadsworth E; Sandberg AL
    Infect Immun; 1988 Jan; 56(1):252-8. PubMed ID: 2961702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the extracellular C3d-binding protein of Candida albicans.
    Saxena A; Calderone R
    Infect Immun; 1990 Feb; 58(2):309-14. PubMed ID: 2137110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b.
    Heidenreich F; Dierich MP
    Infect Immun; 1985 Nov; 50(2):598-600. PubMed ID: 2932390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity.
    Gilmore BJ; Retsinas EM; Lorenz JS; Hostetter MK
    J Infect Dis; 1988 Jan; 157(1):38-46. PubMed ID: 2961817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
    Micklem KJ; Sim RB; Sim E
    Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
    Kalli KR; Ahearn JM; Fearon DT
    J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of cell surface mutants of Candida albicans.
    Whelan WL; Delga JM; Wadsworth E; Walsh TJ; Kwon-Chung KJ; Calderone R; Lipke PN
    Infect Immun; 1990 Jun; 58(6):1552-7. PubMed ID: 2187802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3.
    Eigentler A; Schulz TF; Larcher C; Breitwieser EM; Myones BL; Petzer AL; Dierich MP
    Infect Immun; 1989 Feb; 57(2):616-22. PubMed ID: 2521478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca ions stabilize the binding of complement factor iC3b to the pseudohyphal form of Candida albicans.
    Spötl L; Möst J; Dierich MP
    Infect Immun; 1994 Mar; 62(3):1125-7. PubMed ID: 8112846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.
    Sarrias MR; Franchini S; Canziani G; Argyropoulos E; Moore WT; Sahu A; Lambris JD
    J Immunol; 2001 Aug; 167(3):1490-9. PubMed ID: 11466369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose.
    Hostetter MK; Lorenz JS; Preus L; Kendrick KE
    J Infect Dis; 1990 Apr; 161(4):761-8. PubMed ID: 2138655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for expression of the C3d receptor of Candida albicans in vitro and in vivo obtained by immunofluorescence and immunoelectron microscopy.
    Kanbe T; Li RK; Wadsworth E; Calderone RA; Cutler JE
    Infect Immun; 1991 May; 59(5):1832-8. PubMed ID: 1826896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans C3d receptor, isolated by using a monoclonal antibody.
    Linehan L; Wadsworth E; Calderone R
    Infect Immun; 1988 Aug; 56(8):1981-6. PubMed ID: 2969374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
    Fearon DT; Ahearn JM
    Curr Top Microbiol Immunol; 1990; 153():83-98. PubMed ID: 2153507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.